Bonus Biogroup Stock Today
| BBIXF Stock | USD 0.02 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 66
|
Bonus BioGroup is trading at 0.02 as of the 11th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.02. Bonus BioGroup has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 12th of October 2024 and ending today, the 11th of December 2024. Click here to learn more.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel. Bonus Biogroup is traded on OTC Exchange in the United States. The company has 1.17 B outstanding shares. More on Bonus BioGroup
Moving together with Bonus Pink Sheet
| 0.84 | NVO | Novo Nordisk AS | PairCorr |
| 0.83 | NONOF | Novo Nordisk AS | PairCorr |
| 0.76 | CSLLY | CSL | PairCorr |
| 0.67 | CMXHF | CSL Limited | PairCorr |
| 0.88 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Bonus Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bonus Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Bonus BioGroup [BBIXF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 62.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bonus BioGroup's market, we take the total number of its shares issued and multiply it by Bonus BioGroup's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bonus BioGroup classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 1.17 B outstanding shares.
Bonus BioGroup generates negative cash flow from operations
Check Bonus BioGroup Probability Of Bankruptcy
Ownership AllocationBonus BioGroup holds a total of 1.17 Billion outstanding shares. Bonus BioGroup retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bonus Ownership Details
Bonus BioGroup Risk Profiles
| Mean Deviation | 1.84 | |||
| Standard Deviation | 5.95 | |||
| Variance | 35.4 | |||
| Risk Adjusted Performance | (0.07) |
Bonus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bonus BioGroup without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Bonus BioGroup Corporate Management
| Joseph MBA | Ex Chairman | Profile | |
| Vered Kivity | Head Affairs | Profile | |
| Shai Meretzki | CEO, Founder | Profile | |
| Yoni CPA | Chief Officer | Profile |
Other Information on Investing in Bonus Pink Sheet
Bonus BioGroup financial ratios help investors to determine whether Bonus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus BioGroup security.